Rhythm sells option to buy GI drug to Activis for $40M By: Boston Business Journal via Business Journals October 22, 2014 at 10:23 AM EDT Two months, local biotech Rhythm was planning to raise up to $87 million in an initial public offering... Read More >> Related Stocks: Pfizer